[Lipoid A antibody titer in the human]
- PMID: 3596812
- DOI: 10.1007/BF01650220
[Lipoid A antibody titer in the human]
Abstract
Lipid A is the toxic component of endotoxin in gram-negative bacteria. Antibodies to lipid A are not usually found in healthy persons (or only at a low titer) without a corresponding history of infection. Even gram-negative septicemia is found to be accompanied by only low titers. A completely different situation is seen in patients with chronic or recurrent infections due to Enterobacteriaceae and other gram-negative bacteria. Here it is notable that the antibody titer varies with the type of disorder (e.g. cystitis and pyelonephritis). A severe wound infection, e.g. due to Pseudomonas aeruginosa, also leads to measurable lipid A antibody titers. Varying antibody titers can be observed in cystic fibrosis, Crohn's disease, and severe surgical infections. One can conclude that a significantly elevated antibody titer develops during an extensive tissue involvement of long duration and indeed is caused by tissue inhibition by endotoxin. Based on clinical experience, it can be assumed that lipid A antibodies present in the body have a protective effect in septic shock.
Similar articles
-
[Lipoid A antibody titer in humans].Infection. 1987;15 Suppl 2:S85-8. doi: 10.1007/BF01644199. Infection. 1987. PMID: 3610331 German.
-
Lipid A antibody determinations using ELISA on patients at a children's hospital: a preliminary report.Infection. 1983 Mar-Apr;11(2):84-6. doi: 10.1007/BF01641072. Infection. 1983. PMID: 6862638
-
[Antibodies to lipoid A in the treatment of septic shock].Infection. 1987 Mar-Apr;15(2):146-52. doi: 10.1007/BF01650221. Infection. 1987. PMID: 3298069 Clinical Trial. German.
-
Monoclonal antibodies for treatment of gram-negative infections.Rev Infect Dis. 1989 Nov-Dec;11 Suppl 7:S1564-71. doi: 10.1093/clinids/11.supplement_7.s1564. Rev Infect Dis. 1989. PMID: 2690294 Review.
-
Development and potential use of antibody directed against lipopolysaccharide for the treatment of gram-negative bacterial sepsis.J Trauma. 1990 Dec;30(12 Suppl):S100-6. doi: 10.1097/00005373-199012001-00022. J Trauma. 1990. PMID: 2254968 Review.
Cited by
-
Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.Infection. 1993 Sep-Oct;21(5):297-302. doi: 10.1007/BF01712448. Infection. 1993. PMID: 8300245
-
Endotoxin neutralization as a biomonitor for inflammatory bowel disease.PLoS One. 2013 Jun 24;8(6):e67736. doi: 10.1371/journal.pone.0067736. Print 2013. PLoS One. 2013. PMID: 23826338 Free PMC article.
-
ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens.Infection. 1989 Sep-Oct;17(5):322-8. doi: 10.1007/BF01650719. Infection. 1989. PMID: 2689350
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical